imatinib "viatris" 400 mg filmovertrukne tabletter
viatris limited - imatinibmesilat - filmovertrukne tabletter - 400 mg
rapenin 800 mg filmovertrukne tabletter
pilum pharma a/s - phenoxymethylpenicillinkalium - filmovertrukne tabletter - 800 mg
tenofovir disoproxil "stada" 245 mg filmovertrukne tabletter
stada arzneimittel ag - tenofovirdisoproxil-succinat - filmovertrukne tabletter - 245 mg
atazanavir "stada" 200 mg kapsler, hårde
stada arzneimittel ag - atazanavirsulfat - kapsler, hårde - 200 mg
atazanavir "stada" 300 mg kapsler, hårde
stada arzneimittel ag - atazanavirsulfat - kapsler, hårde - 300 mg
sorafenib "mylan" 200 mg filmovertrukne tabletter
mylan ab - sorafenibtosylat - filmovertrukne tabletter - 200 mg
sunitinib "zentiva" 12,5 mg kapsler, hårde
zentiva k.s. - sunitinib - kapsler, hårde - 12,5 mg
sunitinib "zentiva" 25 mg kapsler, hårde
zentiva k.s. - sunitinib - kapsler, hårde - 25 mg
sunitinib "zentiva" 50 mg kapsler, hårde
zentiva k.s. - sunitinib - kapsler, hårde - 50 mg
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.